RA researchers from around the world recently met online to share the latest findings on treating your disease.
Here are 5 hot takeaways:
- Popular generic drug hydroxychloroquine didn’t cause an abnormal heart rhythm in people with RA or lupus in a new study.
- Upadacitinib, a newer, once-daily 15 mg pill for severe, active RA, is as safe as other JAK-inhibitor drugs, based on new research. However, it has a higher risk of shingles than methotrexate or adalimumab.
- People with RA should try to control their disease with methotrexate before they switch to a biologic or JAK-inhibitor, according to new recommendations.
- Even non-smokers with RA are at higher risk for life-threatening lung disease, per new research–but obesity, longtime smoking, and high CRP levels increase your risk of RA-related lung disease overall.
- This spring, the COVID-19 pandemic lockdown may have caused many people with RA to suddenly change their medication use habits–fear of getting the coronavirus infection was one reason for the shift, according to one survey.